Ontology highlight
ABSTRACT:
SUBMITTER: Whelan JS
PROVIDER: S-EPMC3360547 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature
Whelan J S JS Jinks R C RC McTiernan A A Sydes M R MR Hook J M JM Trani L L Uscinska B B Bramwell V V Lewis I J IJ Nooij M A MA van Glabbeke M M Grimer R J RJ Hogendoorn P C W PC Taminiau A H M AH Gelderblom H H
Annals of oncology : official journal of the European Society for Medical Oncology 20111019 6
<h4>Background</h4>Neoadjuvant chemotherapy improves outcome in osteosarcoma. Determination of optimum regimens for survival, toxicity and prognostic factors requires randomised controlled trials to be conducted.<h4>Patients and methods</h4>Between 1983 and 2002, the European Osteosarcoma Intergroup recruited 1067 patients with localised extremity osteosarcoma to three randomised controlled trials. Standard treatment in each was doxorubicin 75 mg/m(2) and cisplatin 100 mg/m(2). Comparators were ...[more]